GRCE Latest Press Releases

-- November 17, 2025 --

Grace Therapeutics to Participate in 16th Annual Craig-Hallum Alpha Select Conference Globe Newswire 8:00 AM

-- November 13, 2025 --

Grace Therapeutics Announces Second Quarter 2026 Financial Results, Provides Business Update Globe Newswire 8:00 AM

-- November 11, 2025 --

Grace Therapeutics Announces Abstract Accepted for Presentation at Society of Vascular and Interventional Neurology Annual Meeting Globe Newswire 8:30 AM

-- October 23, 2025 --

Grace Therapeutics Secures Approximately $4.0 Million through Common Warrant Exercises Following Acceptance of New Drug Application for GTx-104 for formal FDA Review Globe Newswire 8:00 AM

-- September 22, 2025 --

Grace Therapeutics Pivotal Phase 3 STRIVE-ON Safety Trial Presented at 2025 Neurocritical Care Annual Meeting Globe Newswire 8:00 AM

-- September 18, 2025 --

Grace Therapeutics Granted Sixth U.S. Patent Covering I.V. Dosing Regimen for GTx-104 Globe Newswire 8:30 AM

-- September 4, 2025 --

Grace Therapeutics Announces Presentation at The H.C. Wainwright 27th Annual Global Investment Conference Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software